1. Introduction
===============

Protein tyrosine phosphatases (PTPs) are responsible for selective dephosphorylation of tyrosine residues, and regulate a wide variety of cellular processes including cell growth, differentiation, metabolism, cell-cell communication, cell migration, the immune response, and apoptosis/survival decisions \[[@b1-marinedrugs-04-00009]--[@b3-marinedrugs-04-00009]\]. Since recent studies have demonstrated that loss of protein tyrosine phosphatase-1B (PTP1B) activity resulted in enhancement of insulin sensitivity in addition to decrease in susceptibility to diet-induced obesity \[[@b4-marinedrugs-04-00009]--[@b5-marinedrugs-04-00009]\], specific PTP1B inhibitors have been developed as therapeutic agents in type-2 diabetes and obesity \[[@b6-marinedrugs-04-00009]--[@b7-marinedrugs-04-00009]\]. On the other hand, little attention has been paid to other PTPs such as T-cell PTP (TCPTP), CD45, SHP-1, and SHP-2. Among them TCPTP is the most homologous phosphatase to PTP1B \[[@b8-marinedrugs-04-00009]\], and recent biochemical analysis revealed that TCPTP regulates hematopoietic development, cytokine response, and insulin signaling *in vitro*\[[@b9-marinedrugs-04-00009]--[@b10-marinedrugs-04-00009]\]. In our screening of a number of sponge metabolites against TCPTP and PTP1B, manzamenones B (**2**) and E (**5**) \[[@b11-marinedrugs-04-00009]--[@b12-marinedrugs-04-00009]\] were found to be relatively potent inhibitors, and more potent against TCPTP rather than PTP1B. In this paper we describe inhibitory activity of manzamenones A\~F (**1**\~**6**) \[[@b11-marinedrugs-04-00009]--[@b12-marinedrugs-04-00009]\] against TCPTP and PTP1B, and show manzamenones B (**2**) and E (**5**) to be relatively potent inhibitors against TCPTP.
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2. Results and Discussion
=========================

The inhibitory effects against TCPTP of manzamenones A\~F (**1**\~**6**) were examined as follows. The hydrolysis of *p*-nitrophenyl phosphate (pNPP) by TCPTP was monitored by absorbance at 405 nm in the presence and absence of 5 μM of compounds **1**\~**6** ([Fig. 1](#f1-marinedrugs-04-00009){ref-type="fig"}). Manzamenones A (**1)** and B (**2**) showed inhibitory activities against TCPTP, while manzamenone D (**4**) did not show such activity. The IC~50~ values of compounds **1**\~**6** are shown in [Table 1](#t1-marinedrugs-04-00009){ref-type="table"}. The IC~50~ values of relatively potent compounds **2** and **5**, possessing a carboxylic acid functionality in the side chain, were 2.5 and 3.2 μg/ml, respectively, while compound **1**, the C-5 epimer of **2**, and compounds **3** and **6**, the ethyl or *n*-butyl ester of **1**, respectively, showed less inhibitory activity than **2**. On the other hand, compound **4**, a simple amide at C-5 of **1**, did not show such activity. Thus, the presence of a carboxylic acid or ester functionality and the stereochemistry at C-5 may be important for the inhibitory activity.

Next, inhibitory activities of manzamenones A\~F (**1**\~**6)** against PTP1B were examined ([Table 1](#t1-marinedrugs-04-00009){ref-type="table"}). Compounds **2** and **5** showed inhibitory activities against PTP1B with IC~50~ values of 10.8 and 13.5 μM, respectively, whereas the other compounds did not show such activity. Although many PTP inhibitors have been reported so far, compounds **2** and **5** are the first inhibitors showing significant selectivity to TCPTP over PTP1B. No inhibitory effects of compounds **1**\~**6** against PP1 and PP2A, Ser/Thr protein phosphatases, and A-kinase, one of Ser/Thr protein kinase ([Table 1](#t1-marinedrugs-04-00009){ref-type="table"}) were observed. Therefore, compounds **2** and **5** may interact mainly with the catalytic site of PTPs, with preference to TCPTP rather than PTP1B.

Since manzamenone B (**2**) showed relatively potent inhibitory activity against TCPTP, its inhibition kinetics were analyzed ([Fig. 2](#f2-marinedrugs-04-00009){ref-type="fig"}). The inhibition mode of **2** was a mixed type one as shown in [Fig. 2A](#f2-marinedrugs-04-00009){ref-type="fig"}, suggesting that **2** might interact with the catalytic center and peripheral site(s) of TCPTP. The Ki value for inhibition of TCPTP by **2** was calculated to be 2.2 μM ([Fig. 2B](#f2-marinedrugs-04-00009){ref-type="fig"}).

In this study, manzamenones B (**2**) and E (**5**) were found to be relatively potent inhibitors against TCPTP rather than TCP1B. Compounds **2** and **5** may be useful bioprobes for studies of TCPTP functions as well as drug leads of selective TCPTP inhibitors.

3. Experimental Section
=======================

3.1. Compounds
--------------

Manzamenones A\~F (**1**\~**6**) were supplied as described previously \[[@b11-marinedrugs-04-00009]\].

3.2. Bacterial expression of recombinant proteins
-------------------------------------------------

For bacterial expression of TCPTP as GST (glutathione S-transferase)-fusion protein, the coding regions, amplified by PCR, were subcloned into pGEX-6P-3 (Amersham Biosciences, Piscataway, NJ, U.S.A.). GST-PTP-1B \[[@b13-marinedrugs-04-00009]\] was expressed in *Escherichia coli* and purified as previously described \[[@b13-marinedrugs-04-00009]\].

3.3. Inhibitory activity against protein tyrosine phosphatases
--------------------------------------------------------------

The inhibitory activity of sponge metabolites against TCPTP and PTP1B was examined using *p-*nitrophenyl phosphate (pNPP) as a substrate. An assay mixture (100 μl) containing 100 mM sodium acetate (pH5.0)/1.6 mM dithiothreitol/1 mM pNPP, and enzyme was incubated at 30 °C for 10min. Reactions were terminated by addition of 125 μl of 1M NaOH and 225 μl of each quenched reaction mixture was then added to a well of a 96-well titer plate where the absorbance was read at 405 nm using a microplate spectrophotometer (TECAN). IC~50~ values of inhibitors were obtained on the basis of the data at the concentrations of 1, 2, 5 and 10 μM of compounds **1\~6**. Activities for PP1, PP2A and A-kinase were analyzed as previously described \[[@b14-marinedrugs-04-00009]\].

3.4. Determination of Ki values
-------------------------------

The initial rate at 10 different substrate concentrations (0.60, 0.70, 0.75, 0.85, 0.90, 1.0, 1.25, 1.5, 2.0 and 2.5 mM) was measured at three different inhibitor concentrations (2, 4 and 6 μM). The inhibition pattern was evaluated using Lineweaver-Burk plot, and the Ki values were obtained as the X-intercept by linear regression of the plot of Km versus inhibitor concentration.
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![Progress of *p*-nitrophenyl phosphate hydrolysis by T-Cell protein tyrosine phosphatase in the absence and presence of manzamenones (**1**, **2**, and **4**). 0.125 μM TCPTP was added to the reaction buffer containing 1mM pNPP, and incubated in the presence of 5 μM each of **1** (□), **2** (○) and **4** (△), or absence of inhibitor (×) at 30 °C. The reaction was continuously monitored at 405 nm by spectrophotometer.](marinedrugs-04-00009f1){#f1-marinedrugs-04-00009}

![Manzamenone B (**2**) behaves as a mixed-type inhibitor of TCPTP. (A) Lineweaver-Burk plot. The activity of TCPTP was measured as described in the experimental section in the presence of the following concentrations of **2**: (×) 0 μM; (△) 2 μM; (□) 4 μM; (○) 6 μM. Substrate concentrations used were 0.60, 0.70, 0.75, 0.85, 0.90, 1.0, 1.25, 1.5, 2.0 and 2.5 mM. (B) Secondary replots of the Lineweaver-Burk plot: Km versus various concentrations of **2**.](marinedrugs-04-00009f2){#f2-marinedrugs-04-00009}

###### 

Inhibitory Activities of Manzamenones A\~F (**1**\~**6**) against Protein Tyrosine Phosphatases.

  IC~50~ values (μM)                        
  -------------------- ------ ------ ------ ------
  **1**                9.1    \>20   \>50   \>50
  **2**                2.5    10.8   \>50   \>50
  **3**                7.6    \>20   \>50   \>50
  **4**                \>20   \>20   \-     \-
  **5**                3.2    13.5   \>50   \>50
  **6**                12.6   \>20   \-     \-
